Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD

AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...

November 11, 2019 | Monday | News
World first clinical trial commences in alcohol use disorder

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol ...

October 28, 2019 | Monday | News
SCRI honors Clinical Research Coordinators by Distinguished Contributor Award 2019

The Singapore Clinical Research Institute (SCRI), on 22 Oct 2019, announce the nine winners of the inaugural Distinguish...

October 22, 2019 | Tuesday | News
ASLAN enrolls first patient to study ASLAN004 targeting Atopic Dermatitis

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced on 22 Oct 2019, the...

October 22, 2019 | Tuesday | News
Rentschler Biopharma to expand Japanese operation base

Germany based Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biop...

October 23, 2019 | Wednesday | News
ImaginAb inks pact with three global pharma companies

ImaginAb, Inc., a leading clinical-stage immuno-oncology imaging company has announced the signing of a multi-party coll...

October 15, 2019 | Tuesday | News
Thermo Fisher expands clinical trials capabilities in China

Thermo Fisher Scientific, the world leader in serving science, announced an expansion of its integrated clinical trials ...

September 26, 2019 | Thursday | News
WCG KMR group invites Biopharma companies to enroll in Clinical Trial Cost Study

The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announced on 17 Sep 2019 that the enrolme...

September 20, 2019 | Friday | News
Japan's Solasia set to start trials for Darinaparsin

Solasia Pharma KK has  announced that the darinaparsin Phase 2 study patient registration has reached the targ...

September 20, 2019 | Friday | News
ASLAN presents Ph2 study data for Varlitinib tested on BTC patients

ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, on 19 Sep 2019 announced late...

September 19, 2019 | Thursday | News
Covance unveils new R&D center in Shanghai

LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, has announced that it...

September 17, 2019 | Tuesday | News
Novotech highlights South Korea's plans on clinical trials advancements

Asia-Pacific specialist CRO Novotech has welcomed the South Korean Comprehensive Five-year Plan for the Advancement of C...

September 16, 2019 | Monday | News
Strekin AG completes patient recruitment in RESTORE Ph3 of STR001

Strekin AG, a biopharmaceutical company focused on treatments for hearing loss, on 12 Sep 2019, announced that it has su...

September 15, 2019 | Sunday | News
IBI303 results for Ankylosing Spondylitis published in "The Lancet Rheumatology”

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high quality medicine...

September 2, 2019 | Monday | News
Ascletis receives IND approval for its NASH drug

Ascletis Pharma Inc., an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical need...

August 28, 2019 | Wednesday | News
Abstract on Ph2 study of Varlitinib gets acceptance for oral prentation at CSCP 2019

ASLAN Pharmaceuticals a clinical-stage oncology and immunology focused biopharma company, on 27 August 2019, announ...

August 27, 2019 | Tuesday | News
First patient dosed for Phase I/II trial of avapritinib in advanced GIST

CStone Pharmaceuticals, on 26 August 2019, announced that the first patient in China has been dosed in Phase I/II b...

August 26, 2019 | Monday | News
New trial to evaluate an investigational drug for Parkinson's disease

Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...

August 26, 2019 | Monday | News